A comparison of methods of pathogen inactivation of FFP
- 11 January 2011
- journal article
- research article
- Published by Wiley in Vox Sanguinis
- Vol. 100 (2), 169-178
- https://doi.org/10.1111/j.1423-0410.2010.01374.x
Abstract
Introduction Current methods for pathogen inactivation of plasma involve four major processes using solvent–detergent (SD), methylene blue (MB), amotosalen and riboflavin as additives. Three of these methods involve the use of visible or ultraviolet light. Methods A comparison of the four methods was made using publications in Medline, Pubmed, Embase and Biosis to obtain data on the logistics of use, the quality of the plasma proteins and the effectiveness of pathogen inactivation. Results Three of the methods, MB, amotosalen and riboflavin, are designed for use in a blood bank; the SD method is generally applied at a centralized manufacturing centre and involves large plasma pools. All methods result in a reduction in protein values with the per cent retention of FVIII activity in the range of 67–78% and fibrinogen of 65–84%. Protein S and alpha2‐antiplasmin are lower following solvent–detergent treatment. Alterations in fibrinogen structure have been reported with methylene blue. Discussion Three of the methods are designed for small volume use in a blood bank. All four methods have some effect on the coagulant proteins; however, the final concentrations are within regulated limits. While there is variability in the effectiveness against pathogens, direct comparison is difficult because of the methodologies used. Nonetheless, all are effective in inactivating HIV and other lipid‐enveloped pathogens. Clinical studies on the effectiveness of these products are surprisingly sparse, and no randomized clinical trials have yet been performed with amotosalen or riboflavin plasmas.Keywords
This publication has 71 references indexed in Scilit:
- Characterization of plasma protein activity in riboflavin and UV light-treated fresh frozen plasma during 2 years of storage at −30°CVox Sanguinis, 2010
- The influence of riboflavin photochemistry on plasma coagulation factorsTransfusion and Apheresis Science, 2009
- Methylene blue‐photoinactivated plasma versus quarantine fresh frozen plasma in thrombotic thrombocytopenic purpura: a multicentric, prospective cohort studyBritish Journal of Haematology, 2008
- Coagulation function in fresh-frozen plasma prepared with two photochemical treatment methods: methylene blue and amotosalenTransfusion, 2007
- The experience of treating patients with thrombotic thrombocytopenic purpura with solvent detergent plasma – response to McCarthyBritish Journal of Haematology, 2006
- Methylene blue‐photoinactivated plasma vs. fresh‐frozen plasma as replacement fluid for plasma exchange in thrombotic thrombocytopenic purpuraVox Sanguinis, 2004
- The effect of virus inactivation on coagulation factors in therapeutic plasmaBritish Journal of Haematology, 2000
- The effect of virus inactivation on coagulation factors in therapeutic plasmaBritish Journal of Haematology, 2000
- Resistance of Vaccinia Virus to Inactivation by Solvent/Detergent Treatment of Blood ProductsBiologicals, 2000
- Cryosupernatant as replacement fluid for plasma exchange in thrombotic thrombocytopenic purpuraBritish Journal of Haematology, 1996